Canada markets closed

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.1300+0.3300 (+18.33%)
At close: 04:00PM EDT
2.1700 +0.04 (+1.88%)
After hours: 07:18PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
4,038
6,044
4,754
2,030
2,203
Selling General and Administrative
7,422
8,534
7,339
10,784
2,397
Total Operating Expenses
11,459
14,578
12,093
12,814
4,600
Operating Income or Loss
-11,459
-14,578
-12,093
-12,814
-4,600
Total Other Income/Expenses Net
-
-
-
66.503
-
Income Before Tax
-11,459
-14,578
-12,093
-12,748
-4,600
Income from Continuing Operations
-11,459
-14,578
-12,093
-12,748
-4,600
Net Income
-11,459
-14,578
-12,093
-12,748
-4,600
Net Income available to common shareholders
-11,459
-14,578
-12,093
-12,748
-4,600
Basic EPS
-1.05
-
-1.12
-1.49
-0.48
Diluted EPS
-1.05
-
-1.12
-1.49
-0.48
Basic Average Shares
12,114
-
10,816
8,536
9,541
Diluted Average Shares
12,114
-
10,816
8,536
9,541